KENALOG-10 INJECTION
BRISTOL-MYERS SQUIBB CANADA
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of KENALOG-10 INJECTION in Canada?
Yes. KENALOG-10 INJECTION 10MG has an active shortage reported to Health Canada (last updated August 14, 2026).
Why is KENALOG-10 INJECTION not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will KENALOG-10 INJECTION be available again?
The manufacturer's estimated resolution date is December 31, 2026. This is an estimate and can change; follow this page to get an email when the status changes.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
TRIADERM ONT 0.1%
TARO PHARMACEUTICALS INC
ARISTOCORT C CRM 0.5%
LEDERLE CYANAMID CANADA INC.
ARISTOCORT R CRM 0.1%
LEDERLE CYANAMID CANADA INC.
KENALOG ONT 0.1%
SQUIBB CANADA INC., DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC.
ARISTOCORT R ONT 0.1%
LEDERLE CYANAMID CANADA INC.
TRIADERM ONT 0.025%
TARO PHARMACEUTICALS INC
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
Estimated Resolution
2026-12-31
~3 months remaining (estimate)
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
01999761
Strength
10MG
Dosage Form
SUSPENSION
Route
INTRASYNOVIAL INTRADERMAL INTRABURSAL INTRA-ARTICULAR
Active Ingredient
TRIAMCINOLONE ACETONIDE
Tier
Unrated
Last Updated
2026-08-14
Reason for Shortage
Disruption of the manufacture of the drug.
Other Products from BRISTOL-MYERS SQUIBB CANADA
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
100MG · DIN 02281066
0.5MG · DIN 02282224
120000000CELLS · DIN 02527138
10MG · DIN 02532565
15MG · DIN 02532573
5MG · DIN 02532557
2.5MG · DIN 02532549
100MG · DIN 00360414
125MG · DIN 02163675
250MG · DIN 02163683
250MG · DIN 02163659
500MG · DIN 02163667